Literature DB >> 24319185

Utilization of mouse models to decipher natural killer cell biology and potential clinical applications.

Can M Sungur1, William J Murphy.   

Abstract

Natural killer (NK) cells represent a key component of innate immunity. The utility of mouse models to recapitulate the human immune response has been a matter of ongoing debate, especially with regard to NK cells. However, mouse models of NK cells have provided significant advancements in our understanding of the biology of the cells that bridge these species. Initial characterization of NK cell activity was in mouse hematopoietic stem cell transplantation models. Recent findings include uncovering functionally disparate subsets of NK cells based on unique inhibitory receptor expression patterns, the existence of memory-like NK cells, and immunoregulatory NK cells that affect hematopoiesis and T-cell function. In addition, the biology of these cells with regard to MHC-binding receptors that affect NK cell subset maturation and function in the context of licensing, the importance of cytokines such as IL-15 in their development and maintenance, and evidence of NK exhaustion have been initially studied in mice. Many of these findings have been validated in clinical studies and demonstrate the significant wealth of knowledge that can be obtained by mouse models. However, it is important to understand the limitations and conditions of the mouse models, particularly when studying NK cells in hematopoietic stem cell transplantation and cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24319185     DOI: 10.1182/asheducation-2013.1.227

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  14 in total

1.  Bitter Melon Enhances Natural Killer-Mediated Toxicity against Head and Neck Cancer Cells.

Authors:  Sourav Bhattacharya; Naoshad Muhammad; Robert Steele; Jacki Kornbluth; Ratna B Ray
Journal:  Cancer Prev Res (Phila)       Date:  2017-05-02

2.  Detection and viability of murine NK cells in vivo in a lymphoma model using fluorine-19 MRI.

Authors:  Lawrence M Lechuga; Matthew H Forsberg; Kirsti L Walker; Kai D Ludwig; Christian M Capitini; Sean B Fain
Journal:  NMR Biomed       Date:  2021-08-18       Impact factor: 4.044

Review 3.  A research-driven approach to the identification of novel natural killer cell deficiencies affecting cytotoxic function.

Authors:  Michael T Lam; Emily M Mace; Jordan S Orange
Journal:  Blood       Date:  2020-02-27       Impact factor: 22.113

4.  Amphotericin B, an Anti-Fungal Medication, Directly Increases the Cytotoxicity of NK Cells.

Authors:  Nayoung Kim; Ji-Wan Choi; Hye-Ran Park; Inki Kim; Hun Sik Kim
Journal:  Int J Mol Sci       Date:  2017-06-13       Impact factor: 5.923

5.  Ginsenoside F1 Promotes Cytotoxic Activity of NK Cells via Insulin-Like Growth Factor-1-Dependent Mechanism.

Authors:  Hyung-Joon Kwon; Heejae Lee; Go-Eun Choi; Soon Jae Kwon; Ah Young Song; So Jeong Kim; Woo Seon Choi; Sang-Hyun Hwang; Sun Chang Kim; Hun Sik Kim
Journal:  Front Immunol       Date:  2018-11-28       Impact factor: 7.561

Review 6.  Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer Cells.

Authors:  Andrea M Chambers; Kyle B Lupo; Sandro Matosevic
Journal:  Front Immunol       Date:  2018-11-08       Impact factor: 7.561

7.  Key features and homing properties of NK cells in the liver are shaped by activated iNKT cells.

Authors:  Stephanie Trittel; Benedict J Chambers; Ulrike Heise; Carlos A Guzmán; Peggy Riese
Journal:  Sci Rep       Date:  2019-11-08       Impact factor: 4.379

8.  Clonal expansion and compartmentalized maintenance of rhesus macaque NK cell subsets.

Authors:  Chuanfeng Wu; Diego A Espinoza; Samson J Koelle; Di Yang; Lauren Truitt; Heinrich Schlums; Bernard A Lafont; Jan K Davidson-Moncada; Rong Lu; Amitinder Kaur; Quirin Hammer; Brian Li; Sandhya Panch; David A Allan; Robert E Donahue; Richard W Childs; Chiara Romagnani; Yenan T Bryceson; Cynthia E Dunbar
Journal:  Sci Immunol       Date:  2018-11-02

9.  An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome.

Authors:  Aleksandra Gil-Krzewska; Mezida B Saeed; Anna Oszmiana; Elizabeth R Fischer; Kathryn Lagrue; William A Gahl; Wendy J Introne; John E Coligan; Daniel M Davis; Konrad Krzewski
Journal:  J Allergy Clin Immunol       Date:  2017-12-11       Impact factor: 10.793

Review 10.  Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence.

Authors:  Sean J Judge; William J Murphy; Robert J Canter
Journal:  Front Cell Infect Microbiol       Date:  2020-02-13       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.